The National Institutes of Health this month handed out more than $1.6 million in grant funding to support four microRNA-related research projects including ones focused on the small, non-coding RNAs' roles in women's cancers, as well as their effect on certain bone marrow and immune cells.

The first grant was awarded to University of Georgia researcher Mandi Murph who is investigating whether altered miRNA expression can be used as a biomarker of obesity-related breast and ovarian cancers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.